Literature DB >> 33693584

Implications of an Improved Model of the TSH Receptor Transmembrane Domain (TSHR-TMD-TRIO).

Mihaly Mezei1, Rauf Latif2,3, Bhaskar Das4, Terry F Davies2,3.   

Abstract

The thyroid-stimulating hormone receptor (TSHR) is a G-protein-coupled receptor group A family member with 7 transmembrane helices. We generated 3 new models of its entire transmembrane region using a 600 ns molecular simulation. The simulation started from our previously published model, which we have now revised by also modeling the intracellular loops and the C-terminal tail, adding internal waters and embedding it into a lipid bilayer with a water layer and with ions added to complete the system. We have named this model TSHR-TMD-TRIO since 3 representative dominant structures were then extracted from the simulation trajectory and compared with the original model. These structures each showed small but significant changes in the relative positions of the helices. The 3 models were also used as targets to dock a set of small molecules that are known active compounds including a new TSHR antagonist (BT362), which confirmed the appropriateness of the model with some small molecules showing significant preference for one or other of the structures.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Monte Carlo; TSHR; antagonist; molecular dynamics; small molecule; transmembrane

Mesh:

Substances:

Year:  2021        PMID: 33693584      PMCID: PMC8183494          DOI: 10.1210/endocr/bqab051

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  33 in total

1.  A new method for mapping macromolecular topography.

Authors:  Mihaly Mezei
Journal:  J Mol Graph Model       Date:  2003-03       Impact factor: 2.518

2.  Assessment of protein models with three-dimensional profiles.

Authors:  R Lüthy; J U Bowie; D Eisenberg
Journal:  Nature       Date:  1992-03-05       Impact factor: 49.962

3.  Scalable molecular dynamics with NAMD.

Authors:  James C Phillips; Rosemary Braun; Wei Wang; James Gumbart; Emad Tajkhorshid; Elizabeth Villa; Christophe Chipot; Robert D Skeel; Laxmikant Kalé; Klaus Schulten
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

4.  A new era of GPCR structural and chemical biology.

Authors:  Sébastien Granier; Brian Kobilka
Journal:  Nat Chem Biol       Date:  2012-07-18       Impact factor: 15.040

5.  Prokink: a protocol for numerical evaluation of helix distortions by proline.

Authors:  I Visiers; B B Braunheim; H Weinstein
Journal:  Protein Eng       Date:  2000-09

Review 6.  The thyroid-stimulating hormone receptor: impact of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on multimerization, cleavage, and signaling.

Authors:  Rauf Latif; Syed A Morshed; Mone Zaidi; Terry F Davies
Journal:  Endocrinol Metab Clin North Am       Date:  2009-06       Impact factor: 4.741

Review 7.  TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.

Authors:  Basil Rapoport; Sandra M McLachlan
Journal:  Endocr Rev       Date:  2016-01-22       Impact factor: 19.871

8.  Structure and activation of the TSH receptor transmembrane domain.

Authors:  Ricardo Núñez Miguel; Jane Sanders; Jadwiga Furmaniak; Bernard Rees Smith
Journal:  Auto Immun Highlights       Date:  2016-12-05

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

10.  A Gq Biased Small Molecule Active at the TSH Receptor.

Authors:  Rauf Latif; Syed A Morshed; Risheng Ma; Bengu Tokat; Mihaly Mezei; Terry F Davies
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-26       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.